Clinical Trial Detail

NCT ID NCT04083898
Title Isatuximab, Bendamustine, and Prednisone in Penta-Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

multiple myeloma

Therapies

Bendamustine + Isatuximab + Prednisone

Age Groups: senior adult

No variant requirements are available.